What's breaking now, across thousands of outlets.
A Healthcare Dive analysis of highly anticipated stars data for next year shows a potpourri of winners and losers, though — as expected — the quality scores slipped overall. See how major carriers fared for 2027.
We haven't written up this one. Healthcare Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
This article is from Food for Feed, a series investigating the global fishmeal industry. It is produced by the Outlaw Ocean Project, a news organization based in Washington, D.C., and excerpted by…
KUALA LUMPUR: The Health Ministry's RM47.7 billion allocation under the 2027 Budget is insufficient to meet growing healthcare demands, with development expenditure remaining virtually unchanged, says…
A childhood ADHD diagnosis is linked to a steep decline in adult religious service attendance, especially among Black and Asian American adults.
Israeli pharmaceutical giant Teva receives FDA approval for WELTRUZA, a new long-acting injection for schizophrenia that eliminates the need for daily medication.
The Ghana Atomic Energy Commission (GAEC) has warned Ghanaians about the risk of lung cancer from exposure to radon gas, urging households to improve ventilation by keeping windows open to prevent the…
Teva has received FDA approval for once monthly injectable schizophrenia drug Weltruza. The announcement sent Teva shares gaining in premarket.
